Golden State Equity Partners’s Aehr Test Systems AEHR Stock Holding History

Golden State Equity Partners’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-265	Closed	-$9.83K	–	375
2026 Q1	$9.83K	Buy	+265	New	+$8.48K	﹤0.01%	1301

Other funds holding AEHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Golden State Equity Partners's AEHR Position: Q2 2026 in Review

Golden State Equity Partners sold out of Aehr Test Systems (AEHR) in Q2 2026, closing a stake of 265 shares — an estimated $9.83K sold.

Golden State Equity Partners first reported a position in AEHR in Q1 2026 and held it in 1 quarter. The position peaked at $9.83K in Q1 2026. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

Golden State Equity Partners reported no remaining Aehr Test Systems position as of Q2 2026 after selling out during the quarter.
Golden State Equity Partners sold 265 Aehr Test Systems shares in Q2 2026, an estimated $9.83K.
Golden State Equity Partners first reported a position in Aehr Test Systems in Q1 2026 and held it in 1 quarter.
Golden State Equity Partners's Aehr Test Systems position peaked at $9.83K in Q1 2026.
262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.